Q4 2024 Earnings Call Transcript February 4, 2025 Merck & Co., Inc. misses on earnings expectations. Reported EPS is $1.72 EPS, expectations were $1.85. Operator: Thank you for standing by. Welcome to ...

A Rockville immunotherapy company struck an $8 million deal to take back ownership of the drug candidates it’s been licensing ...

D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...

Tiny microplastics are making their way into the human brain, and new research suggests the problem is getting worse.

Cognitively normal human brain samples collected at autopsy in early 2024 contained more tiny shards of plastic than samples ...

Pharmacies in the UK face significant cuts, so it’s perhaps not surprising that they sell many unevidenced lifestyle products ...

Below is a summary of changes and updates made to the terms over the past 12 months. To see prior months, change the effective date in the top navigation to view a prior publish date. Subscribe to the ...

The roles and responsibilities of CDAOs, and the need to appoint them, are governed by the Controlled Drugs (Supervision of Management and Use) Regulations 2013. be a senior manager of their ...

that GLP-1 drugs lessen stress responses in human beings. Yet not all of the effects were found to be beneficial to the body. The use of GLP-1 medications was linked to GI issues like reflux ...

VRN-07 is under clinical development by ORIC Pharmaceuticals and currently in Phase II for Human Epidermal Growth Factor Receptor ... The company’s pipeline product pipeline includes ORIC-533, a ...

Journal Editorial Report: Congress may demand changes in California. Photo: Allison Dinner/Shutterstock As Los Angeles burned, Gov. Gavin Newsom’s administration plotted an elaborate rescue ...

C1 esterase inhibitor (human ... Takeda Pharmaceutical (Takeda) is a global pharmaceutical company primarily engaged in the research, development, production, and commercialization of ...